Johns Hopkins University supplies Arden & GEM's risk stratification tool
- NHS Arden & GEM CSU
- Call-off from a framework agreement
- 18 November 2025 to 17 November 2026
NHS Arden & GEM CSU bought a risk stratification tool from Johns Hopkins University to help predict patient outcomes.
The tool had to work from clinical data such as prescriptions, diagnoses and events, not just past hospital spending. It needed a tested evidence base and experience of working with NHS data. The CSU wanted to refresh the tool automatically with several years of acute and primary care records.
The CSU ordered the tool through Lot 1 (Clinical Measurement) of the Scope of Dynamic Purchasing System 2.0, run by NHS South, Central and West Commissioning Support Unit. The £229,320 contract runs for a year from November 2025.
- What
- Population health management and risk stratification
- Buyer
- NHS Arden & GEM CSU
- Supplier
- Johns Hopkins University
- Value
- £229,320
- How it was bought
- Call-off from a framework agreement
- Dates and next
- Nov 2025 to Nov 2026